课题基金 / 基金详情

项目摘要

项目成果

Lucien Turner的其他基金

相似基金

相关文献

中文摘要
翻译
项目摘要 基于检查点的癌症免疫疗法的发展使癌症治疗发生了革命性的变化。 十年。尽管许多其他无法治愈的患者已经从这些疗法中看到了长期的好处,但 对于大多数患者来说,长期受益微乎其微,这突显了改进治疗的必要性。的一个主要目标 基于检查点的治疗方法是重振长期刺激的、“耗尽”的CD8+T细胞,以杀死肿瘤。 同样,对这些长期刺激的细胞及其恢复活力的透彻理解 对于未来的治疗发现,CD8+T细胞将继续是必要的。它有 人们越来越认识到,除了表观遗传和转录变化外,细胞代谢 在促进和决定T细胞命运方面起着关键作用。然而,特定的新陈代谢需求 基于检查点的治疗前后耗尽的CD8+T细胞仍不清楚。我的初步研究 提示NAD挽救通路是T细胞活化和分化的一种新的介导物,它 可以在检查站封锁的情况下在治疗方面加以利用。我的数据显示,1)NAD CD8+T细胞的挽救通路是通过刺激TCR和CD28共同调节的,其信号转导途径 已知驱动细胞命运的决定;2)NAD挽救途径在整个过程中是不同需要的 激活初始CD8+T细胞。在T细胞退出静止的过程中,限速酶的活性, NAMPT是细胞生存、增殖和功能所必需的,但不是之后。因此,我假设 NAD挽救途径在慢性和急性背景下是不同的调节和需要的 抗原刺激。在这个提议中,我试图通过阐明特定的信号来解决这一假说 在CD8+T细胞中诱导这一途径的机制(AIM 1)及其调控方式 在精疲力竭的情况下是必需的(目标2)。完成这些目标将阐明CD8+T细胞 细胞亚群调节和需要NAD挽救途径,并将机械地指导未来的设计 旨在重振耗尽的T细胞的免疫疗法。
英文摘要
Project Summary The development of checkpoint based cancer immunotherapy has revolutionized cancer treatment in the last decade. Although many otherwise untreatable patients have seen long term benefit from these therapies, the long-term benefit for most patients is minimal, highlighting a need for improved treatments. A major goal of checkpoint based therapies is to reinvigorate chronically stimulated, “exhausted” CD8+ T cells to kill the tumor. Likewise, a thorough understanding of these chronically stimulated cells and their reinvigoration as compared to acutely stimulated effector CD8+ T cells will continue to be necessary for future therapeutic discovery. It has increasingly become appreciated that in addition to epigenetic and transcriptional changes, cell metabolism plays a critical role in facilitating and determining T cell fate. However, the specific metabolic requirements for exhausted CD8+ T cells before and after checkpoint based treatment remain unclear. My preliminary studies suggest that the NAD salvage pathway is a novel mediator of T cell activation and differentiation, which could be leveraged therapeutically in the context of checkpoint blockade. My data shows that 1) the NAD salvage pathway is regulated in CD8+ T cells through stimulation of both the TCR and CD28, whose signaling is known to drive cell fate determination; 2) The NAD salvage pathway is differentially required throughout the activation of naive CD8+ T cells. During the T cell exit from quiescence, activity of the rate limiting enzyme, NAMPT, is required for cell survival, proliferation, and function, but not after. I thus hypothesize that that the NAD salvage pathway is differentially regulated and required in the context of chronic versus acute antigen stimulation. In this proposal I seek to address this hypothesis by elucidating the specific signaling mechanisms that induce this pathway in CD8+ T cells (Aim 1) and determining how this pathway is regulated and required in the context of exhaustion (Aim 2). Completion of these aims will elucidate how different CD8+ T cell subsets regulate and require the NAD salvage pathway and will mechanistically inform the design of future immunotherapies designed to reinvigorate exhausted T cells.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Elucidating the Regulation and Requirement of the NAD salvage pathway in CD8+ T Cell Exhaustion
  • 批准号:
    10577728
  • 项目类别:
  • 资助金额:
    $4.77万
  • 财政年份:
    2021
  • 负责人:
    Lucien Turner
  • 依托单位:
海外基金